Clinical Trials in Hilton Head Island, United States
Locations / Hilton Head Island, United States
Delta Trials records 15 clinical trials conducted in Hilton Head Island, United States, making it a notable site of clinical research activity. These trials across 127 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Hilton Head Island has changed over time.
15
Total Trials
127
Conditions
1
Terminated since 2020
Browse by condition (127 total)
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iii lung cancer ajcc v8 3 trialsAll Stage iii lung cancer ajcc v8 trials
- Stage ii lung cancer ajcc v8 3 trialsAll Stage ii lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- Stage iia lung cancer ajcc v8 2 trialsAll Stage iia lung cancer ajcc v8 trials
- Stage i lung cancer ajcc v8 2 trialsAll Stage i lung cancer ajcc v8 trials
- All Lung non-squamous non-small cell carcinoma trials
- Stage iib lung cancer ajcc v8 2 trialsAll Stage iib lung cancer ajcc v8 trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Lung non-small cell carcinoma 2 trialsAll Lung non-small cell carcinoma trials
- Stage iiic lung cancer ajcc v8 2 trialsAll Stage iiic lung cancer ajcc v8 trials
- Multiple myeloma 2 trialsAll Multiple myeloma trials
- All Unresectable lung non-small cell carcinoma trials
- Recurrent lymphoma 1 trialAll Recurrent lymphoma trials
- All Prognostic stage iiib breast cancer ajcc v8 trials
- All Stage iiib ovarian cancer ajcc v8 trials